3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

Yahoo FinanceJun 30 06:53 ET

If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

Yahoo FinanceJun 29 11:34 ET

Express News | Shares of Altimmune Are Trading Higher After a NYPost Article Highlighted a Study Comparing the Company's Pemvidutide to Ozempic

BenzingaJun 27 10:34 ET

Express News | Watching Altimmune; Traders Circulate New Yor Post Article 'New Weight Loss Drug May Be Better Than Ozempic — Here's How'

BenzingaJun 27 10:26 ET

Why Are Altimmune Shares Trading Lower Wednesday?

Altimmune, Inc. (NASDAQ:ALT) shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's chief financial officer. What To Know: Eisenstadt'

BenzingaJun 26 16:18 ET

Altimmune Drops 15% After Sudden Death of Finance Chief

By Victor Swezey Shares of Altimmune fell Wednesday after Chief Financial Officer Richard Eisenstadt died suddenly. In afternoon trading, the stock was down 15% to $6.31. Shares are still up 83% in

WSJJun 26 15:58 ET